Ms Botham highlighted her father's charity work through the Beefy's Charity Foundation, which supports several causes ...

Sarah Botham said it had "never been a secret" the independent crossbencher's attendance in Parliament would be limited due ...

Sarah Botham points out her peerage parent ‘always stated he would not be clocking in simply to get his allowance’ ...

A new treatment that could prevent blindness in children with the CLN2 type Batten disease has been trialed by clinicians and ...

Neurogene reports interim Phase 1/2 trial results for NGN-401 gene therapy in treating pediatric Rett syndrome, showing ...

When looking at Neurogene’s stock performance year-to-date, it’s hard to ignore the impressive +269.09% increase. However, this recent downturn suggests that the market is responding to something ...

NEW YORK – Neurogene on Monday said after the market closed that it will stop advancing NGN-101 as a treatment for CLN5 Batten disease, a very rare genetic disorder. The New York-based company said it ...

Separately, Neurogene also shared its plans to discontinue development of a gene therapy for Batten disease after the Food ...

Neurogene has a $903M market cap with two phase 1/2 assets, NGN-401 for Rett Syndrome and NGN-101 for CLN5 Batten Disease.

In a new study, a team of researchers, including Anneliene Jonker, has published, in Nature Reviews Drug Discovery, the first ...

The news led to a stock surge on expectations that forthcoming data for the company’s experimental gene therapy for Rett ...

Taiwan suspended work and classes on some outlying islands and fishers secured their boats Wednesday as authorities warned approaching Super Typhoon Kong-rey could trigger landslides. Strong ...